Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection.

Perez David; Dakhili Seyed Tabatabaei; Bergman Cody; Dufour Jennifer; Wuest Melinda; Wuest Frank; Velazquez-Martinez Carlos

首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection.

【24h】

Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection.

机译：FoxM1抑制剂的发展作为潜在的治疗剂：富氧化Foxm1作为正电子爆震断层扫描（PET）探针的初始步骤，用于三重阴性乳腺癌检测。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Labelled Compounds and Radiopharmaceuticals》 |2019年第s1期|共2页
作者
Perez David; Dakhili Seyed Tabatabaei; Bergman Cody; Dufour Jennifer; Wuest Melinda; Wuest Frank; Velazquez-Martinez Carlos;
展开▼
作者单位

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

Univ Alberta Edmonton AB Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
入库时间 2022-08-20 09:29:58

相似文献

外文文献
专利

1. Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection. [J] . Perez David, Dakhili Seyed Tabatabaei, Bergman Cody, Journal of Labelled Compounds and Radiopharmaceuticals . 2019,第S1期

机译：FoxM1抑制剂的发展作为潜在的治疗剂：富氧化Foxm1作为正电子爆震断层扫描（PET）探针的初始步骤，用于三重阴性乳腺癌检测。
2. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. [J] . Hillner BE, Siegel BA, Liu D, Journal of Clinical Oncology . 2008,第13期

机译：仅正电子发射断层扫描/计算机断层扫描和正电子发射断层扫描（PET）对癌症患者预期管理的影响：美国国家肿瘤PET登记系统的初步结果。
3. An economic evaluation of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence. [J] . Auguste P, Barton P, Hyde C, Health technology assessment: HTA . 2011,第18期

机译：对诊断乳腺癌复发进行正电子发射断层扫描（PET）和正电子发射断层扫描/计算机断层扫描（PET / CT）的经济评估。
4. Pre-reconstruction rigid body registration for positron emission tomography: An initial validation against ground truth [C] . Nordberg Peter, Declerck Jerome, Brady Michael 32nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2010

机译：正电子发射断层扫描的重建前刚体配准：针对地面真相的初步验证
5. Development of serotonin transporter brain imaging agents for use in positron emission tomography and single photon emission computed tomography. [D] . Wang, Julie L. 2010

机译：血清素转运蛋白脑成像剂的开发，用于正电子发射断层扫描和单光子发射计算机断层扫描。
6. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging [O] . Masoud Sadeghzadeh, Barbara Wenzel, Daniel Gündel, 2020

机译：单羧酸转运蛋白配体FACH的新型类似物的开发和正电子发射断层扫描（PET）成像的一种潜在放射性示踪剂的生物学验证
7. Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry [O] . Bruce E. Hillner, Barry A. Siegel, Dawei Liu, 2015

机译：正电子发射断层扫描/计算机断层扫描和正电子发射断层扫描（pET）对癌症患者预期管理的影响：来自国家肿瘤学pET登记处的初步结果

Development of FOXM1 inhibitors as potential theranostic agents: initial steps in the validation of FOXM1 as a positron emission tomography (PET) probe for triple negative-breast cancer detection.

著录项

相似文献

相关主题

期刊订阅